Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.

類似資料

• Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
  著者:: Eaton, C, 等
  出版事項: (2004)
• Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
  著者:: Holen, I, 等
  出版事項: (2002)
• Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
  著者:: Holen, I, 等
  出版事項: (2002)
• Role of osteoprotegerin (OPG) in cancer.
  著者:: Holen, I, 等
  出版事項: (2006)
• The role of osteoprotegerin in breast and prostate cancer
  著者:: Holen, I, 等
  出版事項: (2002)